Sensible Biotechnologies
Unlocking the next generation of mRNA medicines
Oxford, United Kingdom · Founded 2021 · $4.2M raised
- Headquarters
- Oxford
- Employees
- 11–50
- Founded
- 2021
- Website
- sensible.bio
- Total Funding
- $4.2M
- Last Round
- $4.2M Pre-SeedApr 2023
- Rounds
- 1
About
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
Summary
Sensible Biotechnologies is a Biotech company based in Oxford, United Kingdom, founded in 2021. It has raised $4.2M in total across 1 round, most recently a $4.2M Pre-Seed round in Apr 2023. Investors include BlueYard Capital, Amino Collective and Civilization Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2023
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company